Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

Journal of Experimental Medicine

Volumn 183, Issue 1, 1996, Pages 87-97

  Zitvogel, Laurence ^a   Mayordomo, Jose I ^a   Tjandrawan, Tjendimin ^a   DeLeo, Albert B ^a   Clarke, Martha R ^a   Lotze, Michael T ^a   Storkus, Walter J ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROTEIN; TUMOR VACCINE;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELLULAR IMMUNITY; DENDRITIC CELL; EXPERIMENTAL NEOPLASM; FEMALE; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD86; CYTOKINES; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOTHERAPY, ADOPTIVE; LYMPH NODES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; PEPTIDES; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS;

EID: 0030058647     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.1.87     Document Type: Article

References (50)

1. Storkus, W.J., and M.T. Lotze. 1995. Biology of tumor antigens: tumor antigens recognized by immune cells: In Biologic Therapy of Cancer. 2nd ed. V.T. DeVita, S. Hellman, and S.A. Rosenberg, editors, J B. Lippincott Company, Philadelphia, PA. 64-77.
2. Mayordomo, J.I., T. Zorina, W.J. Storkus, C. Celluzzi, L.D. Falo, C.J. Melief, T. Ildstad, W.M. Kast, A.B. DeLeo, and M.T. Lotze. 1995. Nature Med. 1:1297-1302.
3. Lethe, B., B. Van den Eynde, A. Van Pel, G. Corradin, and T. Boon. 1992. Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide. Eur. J. Immunol. 22:2283-2288.
4. Boon, T., J. Cerottini, B. Van den Eynde, P. Van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337-365.
5. Cox, A.L., J. Skipper, Y. Chen, R.A. Henderson, T.L. Darrow, J. Shabanowitz, V.H. Engelhard, D.F. Hunt, and C.L. Slingluff, Jr. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Wash. DC). 264:716-719.
6. Berendt, M.J., and R.J. North. 1980. T cell-mediated suppression of antitumor immunity. An explanation for progressive growth of an immunogenic tumor. J. Exp. Med. 151:69-80.
7. Tepper, R.I., and J.J. Mule. 1994. Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther. 5:153-164.
8. Pardoll, D.M. 1995. Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol. 13:399-415.
9. Zitovogel, L., H. Tahara, P.D. Robbins, W.J. Storkus, M.R. Clarke, M.J. Nalesnik, and M.T. Lotze. 1995. Cancer immunotherapy of established tumors with interleukin-12 (IL-12): effective delivery by genetically engineered fibroblasts. J. Immunol. In press.
10. Huang, A.Y.C., P. Golumbeck, M. Ahmadzadeh, E. Jaffee, D.M. Pardoll, and H. Levitsky. 1994. The role of bone marrow-derived cells in presenting class I-restricted tumor antigens. Science (Wash. DC). 264:961-965.
11. Becker, Y. 1993. Dendritic cell activity against primary tumors: an overview. In Vivo. 7:187-191.
12. Steinman, R.M., and Z.A. Cohn. 1973. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137:1142-1162.
13. Storkus, W.J., J.I. Mayordomo, A. DeLeo, L. Zitvogel, T. Tjandrawan, and M.T. Lotze. Dendritic cells pulsed with tumor epitopes elicit potent antitumor CTL in vitro and in vivo Proceedings of the International Association of Immunology. In press.
14. + lymphocytes to peptide antigen in vivo. J. Immunol. 151:6742-6748.
15. + T cells. J. Immunol. 154:4915-4923.
16. Cohen, P.J., P.A. Cohen, S.A. Rosenberg, S.I. Katz, and J.J. Mule. 1994. Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur. J. Immunol. 24:315-319.
17. Porgador, A., and E. Gilboa. 1995. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182: 255-260.
18. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived-peptide-pulsed dendritic cells. Int. Immunol. 5:849-857.
19. Flamand, V., T. Sornasse, K. Thielemans, C. Demanet, M. Bakkus, H. Bazin, F. Thielemans, O. Leo, J. Urbain, and M. Moser. 1994 Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J Immunol. 24:605-610.
20. Celuzzi, C.M., J.I. Mayordomo, W.J. Storkus, M.T. Lotze, and L.D. Falo, Jr. 1996. Peptide-pulsed dendritic cells induce antigen-specific, cytotoxic T lymphocyte-mediated protective tumor immunity. J. Exp. Med. 183:283-287.
21. Storkus, W.J., H.J. Zeh III, R.D. Salter, and M.T. Lotze. 1993. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J. Immunother. 14:94-103.
22. Zorina, T., et al. 1994. Culture of dendritic cells from murine bone marrow supplemented with GM-CSF and TNFα. J. Immunother. 16:247-258.
23. Nanni, P., C. De Giovanni, P.L. Lollini, G. Nicoletti, and G. Prodi. 1983. TS/A: a new metastasizing cell line originated from a BALB/c spontaneous mammary adenocarcinoma. Clin. Exp. Metastasis. 1:373-380.
24. + cytotoxic T lymphocyte. Cancer. Res. 55:124-128.
25. Linsley, P.S., P.M. Wallace, J. Johnson, M.G. Gibson, J.L. Greene, J.A. Ledbetter, C. Singh, and M.A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA4 T-cell activation molecule. Science (Wash. DC). 257:792-795.
26. Sheehan, K.C.F., N.H. Ruddle, and R.D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factor. J. Immunol. 142:3884-3893.
27. Wysocka, M., M. Kubin, L.Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. IL-12 is required for IFNγ production and lethality in LPS-induced shock in mice. Eur. J. Immunol. 25:672-676.
28. Finkelman, F.D., I.M. Katone, J.F. Hurban, Jr., C.M. Snapper, J. Ohara, and W.E. Paul. 1986. Suppression of in vitro polyclonal IgE responses by mAb to BSF-1. Proc. Natl. Acad. Sci. USA. 83:9675-9677.
29. Wilde, D.B., P. Marrack, J. Kappler, D.P. Dialynas, and F.W. Fitch. 1983. Evidence implicating L3T4 in class II MHC antigen reactivity: monoclonal antibody GK1.5 (anti-L3T4) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. J. Immunol. 131:2178-2183.
30. Sarmiento, M., A.L. Glasebrook, and F.W. Fitch. 1980. IgG or IgM mAb reactive with different determinants on the molecular complex Lyt2 antigen block T-cell mediated cytolysis in the absence of complement. J. Immunol. 125:2665-2672.
31. + T cells. J. Immunol. 154:5071-5079.
32. Chen, L., S. Ashe, W.A. Brady, I. Hellstrom, K.E. Hellstrom, J.A. Ledbetter, P. McGowan, and P.S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71:1093-1102.
33. Kennedy, M K., K.S. Picha, K.D. Shanebeck, D.M. Anderson, and K.H. Grabstein. 1994. IL-12 regulates the proliferation of Th1, but not Th2 or Th0 clones. Eur. J Immunol. 24: 2271-2276.
34. Coley, W.B. The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). 1909. John Bale, Sons, & Danielsson. London.
35. Restifo, N.P , I. Bacik, K.R. Irvine, J.W. Yewdell, B.J. McCabe, R.W. Anderson, L.C. Eisenlohr, S.A. Rosenberg, and J.R. Bennink. 1995. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154:4414-4422.
36. Streilein, J.W., S.F. Grammer, T. Yoshikawa, A. Demidem, and M. Vermeer. 1990. Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes. Immunol. Rev. 117:159-183.
37. Grabbe, S., S. Bruvers, R.L. Gallo, T.L. Knisely, R. Nazareno, and R.D. Granstein. 1991. Tumor antigen presentation by murine epidermal cells. J. Immunol. 146:3656-3661.
38. Inaba, K. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with GM-CSF. J. Exp Med. 176.1693-1702.
39. Grabbe, S., S. Beissert, T. Schwarz, and R.D. Granstein. 1995. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol. Today. 16:117-121.
40. Inaba, K., R.M. Steinman, M.W. Pack, H. Aya, M. Anaba, T. Sudo, S. Wolpe, and G. Schuler. 1992. Identification of proliferating dendritic cell precursors in mouse blood. J. Exp. Med. 175:1157-1164.
41. Lu, L., J. Woo, A.S. Rao, Y. Li, S.C. Watkins, S. Qian, T.E. Starzl, A.J. Demetris, and A.W. Thompson. 1994. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J. Exp. Med. 179:1823-1834.
42. Romani, N., S Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P.O. Tritsch, R.M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83-93.
43. Schuler, G., and R.M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:526-546.
44. Franksson, L., M. Petersson, R. Kiessling, and K. Karre. 1993. Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells. Eur. J. Immunol. 23:2606-2613.
45. Knight, S.C., R. Hunt, C. Dore, and P.B. Medawar. 1995. Influence of dendritic cells on tumor growth. Proc. Natl. Acad. Sci. USA. 82:4495-4497.
46. Gajewski, T.F., J.-C. Renaud, A. Van Pel, and T. Boon. 1995. Costimulation with B7-1, IL-6, IL-12 is sufficient for primary generation of murine and tumor cytolytic T lymphocytes in vitro. J Immunol. 154:5637-5648.
47. Kobayashi, M., L. Fritz, M. Ryan, R.M. Hewick, S.C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification, and purification of NKSF, a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-845.
48. + T cells requires the coordinate action of IL-12 and IFNγ and is inhibited by TGF-β. Eur. J. Immunol. 24: 793-798.
49. Shu, U., M. Kimwa, C. You Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce IL-12 production by monocytes via CD40-CD40L interaction. Eur. J. Immunol. 25:1125-1128.
50. Noguchi, Y., E.C. Richards, Y.-T. Chen, and L.J. Old. 1995. Influence of IL-12 on p53 peptide vaccination against established meth A sarcoma. Proc. Natl. Acad. Sci. USA. 92: 2219-2223.